BSX in the 13F filings
Boston Scientific Corp · CUSIP 101137107
- Quarter end
- 30 Sep 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 12 Nov 2024
- Managers listing it
- 40
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q2 2024 and Q3 2024; 35 listed it in both
- Shares listed
- 338,711,877
- combined, among listed positions
- Reported value
- $28.3bn
- combined, at the quarter end
Among the 94 comparable managers: 25 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing BSX in Q3 2024
40 of 40 holders
Largest increases and reductions, by shares
Increases
- Marshall Wace LLPexisting position · 8,240,519 shares now+1,520,039
- Farallon Capital Management LLCexisting position · 5,425,657 shares now+1,316,500
- Capital World Investorsexisting position · 21,683,704 shares now+1,281,968
- Invesco Ltdexisting position · 13,897,654 shares now+1,211,748
- Capital Research Global Investorsexisting position · 4,293,569 shares now+1,002,369
Reductions
- Fidelity (FMR LLC)existing position · 135,196,894 shares now-6,263,772
- MFS Investment Managementexisting position · 25,667,693 shares now-6,117,525
- Citadel Advisors LLCexisting position · 9,793,103 shares now-2,706,764
- Janus Henderson Group Ltdexisting position · 15,745,111 shares now-2,571,951
- Artisan Partners LPexisting position · 12,410,573 shares now-2,255,083
New positions and exits
New (2)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 13 | $3.9bn | n.a. | n.a. |
| Q3 2013 | 17 | $5.3bn | n.a. | n.a. |
| Q4 2013 | 15 | $4.8bn | n.a. | n.a. |
| Q1 2014 | 12 | $5.6bn | n.a. | n.a. |
| Q2 2014 | 15 | $5.1bn | n.a. | n.a. |
| Q3 2014 | 21 | $5.1bn | n.a. | n.a. |
| Q4 2014 | 16 | $5.3bn | n.a. | n.a. |
| Q1 2015 | 18 | $6.7bn | n.a. | n.a. |
| Q2 2015 | 19 | $6.9bn | n.a. | n.a. |
| Q3 2015 | 19 | $6.8bn | n.a. | n.a. |
| Q4 2015 | 20 | $7.4bn | n.a. | n.a. |
| Q1 2016 | 17 | $8.3bn | n.a. | n.a. |
| Q2 2016 | 24 | $10.6bn | n.a. | n.a. |
| Q3 2016 | 26 | $10.4bn | n.a. | n.a. |
| Q4 2016 | 25 | $9.2bn | n.a. | n.a. |
| Q1 2017 | 23 | $11.1bn | n.a. | n.a. |
| Q2 2017 | 26 | $12.7bn | n.a. | n.a. |
| Q3 2017 | 24 | $13.4bn | n.a. | n.a. |
| Q4 2017 | 30 | $11.5bn | n.a. | n.a. |
| Q1 2018 | 32 | $12.4bn | n.a. | n.a. |
| Q2 2018 | 25 | $15.3bn | n.a. | n.a. |
| Q3 2018 | 28 | $17.9bn | n.a. | n.a. |
| Q4 2018 | 28 | $16.2bn | n.a. | n.a. |
| Q1 2019 | 31 | $16.9bn | n.a. | n.a. |
| Q2 2019 | 23 | $19.2bn | n.a. | n.a. |
| Q3 2019 | 23 | $18.2bn | n.a. | n.a. |
| Q4 2019 | 26 | $19.7bn | n.a. | n.a. |
| Q1 2020 | 31 | $13.5bn | n.a. | n.a. |
| Q2 2020 | 29 | $14.1bn | n.a. | n.a. |
| Q3 2020 | 31 | $15.0bn | n.a. | n.a. |
| Q4 2020 | 35 | $13.6bn | n.a. | n.a. |
| Q1 2021 | 29 | $15.7bn | n.a. | n.a. |
| Q2 2021 | 27 | $18.2bn | n.a. | n.a. |
| Q3 2021 | 27 | $18.2bn | n.a. | n.a. |
| Q4 2021 | 26 | $17.4bn | n.a. | n.a. |
| Q1 2022 | 32 | $17.4bn | n.a. | n.a. |
| Q2 2022 | 30 | $14.0bn | n.a. | n.a. |
| Q3 2022 | 29 | $14.5bn | n.a. | n.a. |
| Q4 2022 | 26 | $16.6bn | n.a. | n.a. |
| Q1 2023 | 32 | $18.5bn | n.a. | n.a. |
| Q2 2023 | 37 | $19.6bn | n.a. | n.a. |
| Q3 2023 | 33 | $19.7bn | n.a. | n.a. |
| Q4 2023 | 30 | $20.6bn | 14 | 19 |
| Q1 2024 | 33 | $24.0bn | 13 | 19 |
| Q2 2024 | 35 | $26.8bn | 21 | 15 |
| Q3 2024 | 40 | $28.3bn | 25 | 15 |
| Q4 2024 | 40 | $29.4bn | 18 | 21 |
| Q1 2025 | 44 | $33.1bn | 22 | 21 |
| Q2 2025 | 44 | $33.6bn | 24 | 21 |
| Q3 2025 | 48 | $29.5bn | 29 | 19 |
| Q4 2025 | 49 | $28.5bn | 28 | 22 |
| Q1 2026 | 45 | $17.2bn | 23 | 27 |
| Q2 2026 | 40 | $13.0bn | 30 | 21 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BSX and LLY →BSX and JNJ →BSX and VRTX →Choose a stock to compare with BSX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BSX, latest filings →Back to the 13F Explorer →